2005
DOI: 10.1007/s11926-005-0046-3
|View full text |Cite
|
Sign up to set email alerts
|

Blau syndrome and related genetic disorders causing childhood arthritis

Abstract: Blau Syndrome (BS) is an inheritable disorder characterized by granulomatous polyarthritis, panuveitis, and exanthema. It was described by Edward Blau in 1985, the same year in which Douglas Jabs reported a very similar family. Clinically indistinguishable from early onset sarcoidosis (EOS), both are now known to share a mutated form of caspase recruitment domain-15 (CARD 15), a protein involved in activation of nuclear factor kappa B which is in turn an up-regulator of pro-inflammatory cytokine transcription.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
31
2
3

Year Published

2007
2007
2017
2017

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 63 publications
(37 citation statements)
references
References 31 publications
1
31
2
3
Order By: Relevance
“…The caspase recruitment domain (CARD) 15 gene (also referred to as NOD2 gene) has been pointed as a risk susceptibility factor to develop Blau syndrome (MIM#186580), a chronic inflammatory disorder characterized by skin rash, chronic symmetric arthritis, camptodactyly and recurrent uveitis [1].…”
Section: Introductionmentioning
confidence: 99%
“…The caspase recruitment domain (CARD) 15 gene (also referred to as NOD2 gene) has been pointed as a risk susceptibility factor to develop Blau syndrome (MIM#186580), a chronic inflammatory disorder characterized by skin rash, chronic symmetric arthritis, camptodactyly and recurrent uveitis [1].…”
Section: Introductionmentioning
confidence: 99%
“…O tratamento envolve o uso de AINH em pacientes com quadro clínico leve, enquanto que manifestações mais graves requerem corticoterapia sistêmica 7,119 . Outros tratamentos utilizados são metotrexate e ciclosporina, e o uso de imunobiológicos (etanercepte, infliximabe e anakinra) tem sido descrito, principalmente em pacientes com manifestações oculares refratárias 7,117,119. Síndrome de artrite piogênica asséptica, pioderma gangrenoso e acne (síndrome PAPA)…”
Section: Figura 3 -Exantema Ictisioseforme Em Paciente Com Sarcoidoseunclassified
“…18 Treatment is NSAID-based in patients with mild disease, whereas more severe manifestations require systemic corticosteroid therapy. 7,119 …”
Section: Mevalonate Kinase Deficiency (Mkd) or Hyper-igd And Periodicmentioning
confidence: 99%